SrasV1, PubMed, Corpus, bibRecord, 001D38

Structure-based design and synthesis of highly potent SARS-CoV 3CL protease inhibitors.

Identifieur interne : 001D38 ( PubMed/Corpus ); précédent : 001D37; suivant : 001D39

Structure-based design and synthesis of highly potent SARS-CoV 3CL protease inhibitors.

Auteurs : Yi-Ming Shao ; Wen-Bin Yang ; Hung-Pin Peng ; Min-Feng Hsu ; Keng-Chang Tsai ; Tun-Hsun Kuo ; Andrew H-J Wang ; Po-Huang Liang ; Chun-Hung Lin ; An-Suei Yang ; Chi-Huey Wong

Source :

Chembiochem : a European journal of chemical biology [ 1439-4227 ] ; 2007.

RBID : pubmed:17722121

English descriptors

KwdEn :
- Chemistry, Pharmaceutical (methods), Crystallization, Crystallography, X-Ray (methods), Cysteine Endopeptidases, Drug Design, Hydrogen Bonding, Ligands, Models, Chemical, Molecular Conformation, Protease Inhibitors (chemical synthesis), Protease Inhibitors (pharmacology), Protein Conformation, SARS Virus (enzymology), Viral Proteins (antagonists & inhibitors), X-Rays.
MESH :
- chemical , antagonists & inhibitors : Viral Proteins.
- chemical , chemical synthesis : Protease Inhibitors.
- chemical , pharmacology : Protease Inhibitors.
- chemical : Cysteine Endopeptidases, Ligands.
- enzymology : SARS Virus.
- methods : Chemistry, Pharmaceutical, Crystallography, X-Ray.
- Crystallization, Drug Design, Hydrogen Bonding, Models, Chemical, Molecular Conformation, Protein Conformation, X-Rays.

DOI: 10.1002/cbic.200700254
PubMed: 17722121

Links to Exploration step

pubmed:17722121

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Structure-based design and synthesis of highly potent SARS-CoV 3CL protease inhibitors.</title>
<author><name sortKey="Shao, Yi Ming" sort="Shao, Yi Ming" uniqKey="Shao Y" first="Yi-Ming" last="Shao">Yi-Ming Shao</name>
<affiliation><nlm:affiliation>Genomics Research Center, Academia Sinica, No. 128, Sec. 2, Academia Rd., Taipei City 115, Taiwan, ROC.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Yang, Wen Bin" sort="Yang, Wen Bin" uniqKey="Yang W" first="Wen-Bin" last="Yang">Wen-Bin Yang</name>
</author>
<author><name sortKey="Peng, Hung Pin" sort="Peng, Hung Pin" uniqKey="Peng H" first="Hung-Pin" last="Peng">Hung-Pin Peng</name>
</author>
<author><name sortKey="Hsu, Min Feng" sort="Hsu, Min Feng" uniqKey="Hsu M" first="Min-Feng" last="Hsu">Min-Feng Hsu</name>
</author>
<author><name sortKey="Tsai, Keng Chang" sort="Tsai, Keng Chang" uniqKey="Tsai K" first="Keng-Chang" last="Tsai">Keng-Chang Tsai</name>
</author>
<author><name sortKey="Kuo, Tun Hsun" sort="Kuo, Tun Hsun" uniqKey="Kuo T" first="Tun-Hsun" last="Kuo">Tun-Hsun Kuo</name>
</author>
<author><name sortKey="Wang, Andrew H J" sort="Wang, Andrew H J" uniqKey="Wang A" first="Andrew H-J" last="Wang">Andrew H-J Wang</name>
</author>
<author><name sortKey="Liang, Po Huang" sort="Liang, Po Huang" uniqKey="Liang P" first="Po-Huang" last="Liang">Po-Huang Liang</name>
</author>
<author><name sortKey="Lin, Chun Hung" sort="Lin, Chun Hung" uniqKey="Lin C" first="Chun-Hung" last="Lin">Chun-Hung Lin</name>
</author>
<author><name sortKey="Yang, An Suei" sort="Yang, An Suei" uniqKey="Yang A" first="An-Suei" last="Yang">An-Suei Yang</name>
</author>
<author><name sortKey="Wong, Chi Huey" sort="Wong, Chi Huey" uniqKey="Wong C" first="Chi-Huey" last="Wong">Chi-Huey Wong</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2007">2007</date>
<idno type="RBID">pubmed:17722121</idno>
<idno type="pmid">17722121</idno>
<idno type="doi">10.1002/cbic.200700254</idno>
<idno type="wicri:Area/PubMed/Corpus">001D38</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001D38</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Structure-based design and synthesis of highly potent SARS-CoV 3CL protease inhibitors.</title>
<author><name sortKey="Shao, Yi Ming" sort="Shao, Yi Ming" uniqKey="Shao Y" first="Yi-Ming" last="Shao">Yi-Ming Shao</name>
<affiliation><nlm:affiliation>Genomics Research Center, Academia Sinica, No. 128, Sec. 2, Academia Rd., Taipei City 115, Taiwan, ROC.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Yang, Wen Bin" sort="Yang, Wen Bin" uniqKey="Yang W" first="Wen-Bin" last="Yang">Wen-Bin Yang</name>
</author>
<author><name sortKey="Peng, Hung Pin" sort="Peng, Hung Pin" uniqKey="Peng H" first="Hung-Pin" last="Peng">Hung-Pin Peng</name>
</author>
<author><name sortKey="Hsu, Min Feng" sort="Hsu, Min Feng" uniqKey="Hsu M" first="Min-Feng" last="Hsu">Min-Feng Hsu</name>
</author>
<author><name sortKey="Tsai, Keng Chang" sort="Tsai, Keng Chang" uniqKey="Tsai K" first="Keng-Chang" last="Tsai">Keng-Chang Tsai</name>
</author>
<author><name sortKey="Kuo, Tun Hsun" sort="Kuo, Tun Hsun" uniqKey="Kuo T" first="Tun-Hsun" last="Kuo">Tun-Hsun Kuo</name>
</author>
<author><name sortKey="Wang, Andrew H J" sort="Wang, Andrew H J" uniqKey="Wang A" first="Andrew H-J" last="Wang">Andrew H-J Wang</name>
</author>
<author><name sortKey="Liang, Po Huang" sort="Liang, Po Huang" uniqKey="Liang P" first="Po-Huang" last="Liang">Po-Huang Liang</name>
</author>
<author><name sortKey="Lin, Chun Hung" sort="Lin, Chun Hung" uniqKey="Lin C" first="Chun-Hung" last="Lin">Chun-Hung Lin</name>
</author>
<author><name sortKey="Yang, An Suei" sort="Yang, An Suei" uniqKey="Yang A" first="An-Suei" last="Yang">An-Suei Yang</name>
</author>
<author><name sortKey="Wong, Chi Huey" sort="Wong, Chi Huey" uniqKey="Wong C" first="Chi-Huey" last="Wong">Chi-Huey Wong</name>
</author>
</analytic>
<series><title level="j">Chembiochem : a European journal of chemical biology</title>
<idno type="ISSN">1439-4227</idno>
<imprint><date when="2007" type="published">2007</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Chemistry, Pharmaceutical (methods)</term>
<term>Crystallization</term>
<term>Crystallography, X-Ray (methods)</term>
<term>Cysteine Endopeptidases</term>
<term>Drug Design</term>
<term>Hydrogen Bonding</term>
<term>Ligands</term>
<term>Models, Chemical</term>
<term>Molecular Conformation</term>
<term>Protease Inhibitors (chemical synthesis)</term>
<term>Protease Inhibitors (pharmacology)</term>
<term>Protein Conformation</term>
<term>SARS Virus (enzymology)</term>
<term>Viral Proteins (antagonists & inhibitors)</term>
<term>X-Rays</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="antagonists & inhibitors" xml:lang="en"><term>Viral Proteins</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="chemical synthesis" xml:lang="en"><term>Protease Inhibitors</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en"><term>Protease Inhibitors</term>
</keywords>
<keywords scheme="MESH" type="chemical" xml:lang="en"><term>Cysteine Endopeptidases</term>
<term>Ligands</term>
</keywords>
<keywords scheme="MESH" qualifier="enzymology" xml:lang="en"><term>SARS Virus</term>
</keywords>
<keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Chemistry, Pharmaceutical</term>
<term>Crystallography, X-Ray</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Crystallization</term>
<term>Drug Design</term>
<term>Hydrogen Bonding</term>
<term>Models, Chemical</term>
<term>Molecular Conformation</term>
<term>Protein Conformation</term>
<term>X-Rays</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">17722121</PMID>
<DateCompleted><Year>2008</Year>
<Month>01</Month>
<Day>14</Day>
</DateCompleted>
<DateRevised><Year>2020</Year>
<Month>04</Month>
<Day>18</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Print">1439-4227</ISSN>
<JournalIssue CitedMedium="Print"><Volume>8</Volume>
<Issue>14</Issue>
<PubDate><Year>2007</Year>
<Month>Sep</Month>
<Day>24</Day>
</PubDate>
</JournalIssue>
<Title>Chembiochem : a European journal of chemical biology</Title>
<ISOAbbreviation>Chembiochem</ISOAbbreviation>
</Journal>
<ArticleTitle>Structure-based design and synthesis of highly potent SARS-CoV 3CL protease inhibitors.</ArticleTitle>
<Pagination><MedlinePgn>1654-7</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Shao</LastName>
<ForeName>Yi-Ming</ForeName>
<Initials>YM</Initials>
<AffiliationInfo><Affiliation>Genomics Research Center, Academia Sinica, No. 128, Sec. 2, Academia Rd., Taipei City 115, Taiwan, ROC.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Yang</LastName>
<ForeName>Wen-Bin</ForeName>
<Initials>WB</Initials>
</Author>
<Author ValidYN="Y"><LastName>Peng</LastName>
<ForeName>Hung-Pin</ForeName>
<Initials>HP</Initials>
</Author>
<Author ValidYN="Y"><LastName>Hsu</LastName>
<ForeName>Min-Feng</ForeName>
<Initials>MF</Initials>
</Author>
<Author ValidYN="Y"><LastName>Tsai</LastName>
<ForeName>Keng-Chang</ForeName>
<Initials>KC</Initials>
</Author>
<Author ValidYN="Y"><LastName>Kuo</LastName>
<ForeName>Tun-Hsun</ForeName>
<Initials>TH</Initials>
</Author>
<Author ValidYN="Y"><LastName>Wang</LastName>
<ForeName>Andrew H-J</ForeName>
<Initials>AH</Initials>
</Author>
<Author ValidYN="Y"><LastName>Liang</LastName>
<ForeName>Po-Huang</ForeName>
<Initials>PH</Initials>
</Author>
<Author ValidYN="Y"><LastName>Lin</LastName>
<ForeName>Chun-Hung</ForeName>
<Initials>CH</Initials>
</Author>
<Author ValidYN="Y"><LastName>Yang</LastName>
<ForeName>An-Suei</ForeName>
<Initials>AS</Initials>
</Author>
<Author ValidYN="Y"><LastName>Wong</LastName>
<ForeName>Chi-Huey</ForeName>
<Initials>CH</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>Germany</Country>
<MedlineTA>Chembiochem</MedlineTA>
<NlmUniqueID>100937360</NlmUniqueID>
<ISSNLinking>1439-4227</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D008024">Ligands</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D011480">Protease Inhibitors</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D014764">Viral Proteins</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>EC 3.4.22.-</RegistryNumber>
<NameOfSubstance UI="C099456">3C-like proteinase, Coronavirus</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>EC 3.4.22.-</RegistryNumber>
<NameOfSubstance UI="D003546">Cysteine Endopeptidases</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D002626" MajorTopicYN="N">Chemistry, Pharmaceutical</DescriptorName>
<QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D003460" MajorTopicYN="N">Crystallization</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D018360" MajorTopicYN="N">Crystallography, X-Ray</DescriptorName>
<QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D003546" MajorTopicYN="N">Cysteine Endopeptidases</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D015195" MajorTopicYN="N">Drug Design</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006860" MajorTopicYN="N">Hydrogen Bonding</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008024" MajorTopicYN="N">Ligands</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008956" MajorTopicYN="N">Models, Chemical</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008968" MajorTopicYN="N">Molecular Conformation</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011480" MajorTopicYN="N">Protease Inhibitors</DescriptorName>
<QualifierName UI="Q000138" MajorTopicYN="Y">chemical synthesis</QualifierName>
<QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011487" MajorTopicYN="N">Protein Conformation</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D045473" MajorTopicYN="N">SARS Virus</DescriptorName>
<QualifierName UI="Q000201" MajorTopicYN="Y">enzymology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D014764" MajorTopicYN="N">Viral Proteins</DescriptorName>
<QualifierName UI="Q000037" MajorTopicYN="Y">antagonists & inhibitors</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D014965" MajorTopicYN="N">X-Rays</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2007</Year>
<Month>8</Month>
<Day>28</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2008</Year>
<Month>1</Month>
<Day>15</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2007</Year>
<Month>8</Month>
<Day>28</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">17722121</ArticleId>
<ArticleId IdType="doi">10.1002/cbic.200700254</ArticleId>
<ArticleId IdType="pmc">PMC7162026</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>Curr Opin Struct Biol. 2005 Dec;15(6):664-72</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16263266</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Bioorg Med Chem. 2004 Aug 1;12(15):4081-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15246086</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Bioorg Med Chem Lett. 2005 Jun 15;15(12):3058-62</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15896959</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Chem Biol. 2006 Mar;13(3):261-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16638531</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Curr Top Microbiol Immunol. 2005;287:57-94</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15609509</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Med Chem. 2005 Jun 30;48(13):4469-73</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15974598</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Gen Virol. 2003 Sep;84(Pt 9):2305-2315</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12917450</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Proc Natl Acad Sci U S A. 2003 Nov 11;100(23):13190-5</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14585926</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Med Chem. 2004 Dec 2;47(25):6113-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15566280</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Mol Biol. 2005 Nov 11;353(5):1137-51</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16219322</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Proc Natl Acad Sci U S A. 1998 Feb 3;95(3):939-44</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9448264</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Nat Rev Microbiol. 2003 Dec;1(3):209-18</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15035025</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Chem Biol. 2004 Sep;11(9):1293-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15380189</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Proc Natl Acad Sci U S A. 2004 Jul 6;101(27):10012-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15226499</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>N Engl J Med. 2003 May 15;348(20):1967-76</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12690091</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Med Chem. 2003 Oct 9;46(21):4572-85</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14521419</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Annu Rep Med Chem. 2007 Feb 1;41:183-196</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19649165</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Med Chem. 2005 Nov 3;48(22):6767-71</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16250632</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Bioorg Med Chem. 2005 Sep 1;13(17):5240-52</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15994085</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Chembiochem. 2006 Jul;7(7):1048-55</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16688706</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>PLoS Biol. 2005 Oct;3(10):e324</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16128623</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/PubMed/Corpus

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001D38 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 001D38 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SrasV1
   |flux=    PubMed
   |étape=   Corpus
   |type=    RBID
   |clé=     pubmed:17722121
   |texte=   Structure-based design and synthesis of highly potent SARS-CoV 3CL protease inhibitors.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i   -Sk "pubmed:17722121" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd   \
       | NlmPubMed2Wicri -a SrasV1

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021

	Serveur d'exploration SRAS
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration SRAS

Structure-based design and synthesis of highly potent SARS-CoV 3CL protease inhibitors.

Structure-based design and synthesis of highly potent SARS-CoV 3CL protease inhibitors.

Source :

English descriptors

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki